Edition:
United Kingdom

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

7.30EUR
19 Jul 2019
Change (% chg)

€-0.13 (-1.75%)
Prev Close
€7.43
Open
€7.34
Day's High
€7.46
Day's Low
€7.24
Volume
125,560
Avg. Vol
94,234
52-wk High
€8.07
52-wk Low
€4.78

About

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and... (more)

Overall

Beta: -0.01
Market Cap(Mil.): €139.64
Shares Outstanding(Mil.): 38.42
Dividend: --
Yield (%): --

Financials

  B8FGn.DE Industry Sector
P/E (TTM): -- 29.88 32.66
EPS (TTM): -0.46 -- --
ROI: -184.45 14.90 14.49
ROE: -276.38 16.02 15.79

Earnings vs. Estimates